Evidence map›Paper›PMID 35233680›Full record

ArticleCellular and molecular life sciences : CMLS2022

Ubr1-induced selective endophagy/autophagy protects against the endosomal and Ca

Ben B Wang, Haijin Xu, Sandra Isenmann, Cheng Huang, Xabier Elorza-Vidal, Grigori Y Rychkov, Raúl Estévez, Ralf B Schittenhelm, Gergely L Lukacs, Pirjo M Apaja

Open access · hybridAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Ben B WangLifelong Health, Organelle Proteostasis Diseases, South Australian Health and Medical Research Institute (SAHMRI), 5000 North Terrace, Adelaide, SA, 5000, Australia.
Haijin XuDepartment of Physiology and Cell Information Systems, McGill University, 3655 Promenade Sir-William-Osler, Montréal, QC, H3G 1Y6, Canada.
Sandra IsenmannLifelong Health, Organelle Proteostasis Diseases, South Australian Health and Medical Research Institute (SAHMRI), 5000 North Terrace, Adelaide, SA, 5000, Australia.
Cheng HuangMonash Biomedical Proteomics Facility, Department of Biochemistry, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, 3800, Australia.
Xabier Elorza-VidalUnitat de Fisiologia, Departament de Ciències Fisiològiques, IDIBELL-Institute of Neurosciences, L'Hospitalet de Llobregat, Universitat de Barcelona, Barcelona, Spain.
Grigori Y RychkovLifelong Health, Organelle Proteostasis Diseases, South Australian Health and Medical Research Institute (SAHMRI), 5000 North Terrace, Adelaide, SA, 5000, Australia.
Raúl EstévezUnitat de Fisiologia, Departament de Ciències Fisiològiques, IDIBELL-Institute of Neurosciences, L'Hospitalet de Llobregat, Universitat de Barcelona, Barcelona, Spain.
Ralf B SchittenhelmMonash Biomedical Proteomics Facility, Department of Biochemistry, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, 3800, Australia.
Gergely L LukacsDepartment of Physiology and Cell Information Systems, McGill University, 3655 Promenade Sir-William-Osler, Montréal, QC, H3G 1Y6, Canada. gergely.lukacs@mcgill.ca.
Pirjo M ApajaLifelong Health, Organelle Proteostasis Diseases, South Australian Health and Medical Research Institute (SAHMRI), 5000 North Terrace, Adelaide, SA, 5000, Australia. pirjo.apaja@flinders.edu.au.ORCID http://orcid.org/0000-0002-1622-2332
Instituto de Salud Carlos III · ESMcGill University · CAMonash University · AUUniversity of South Australia · AUFlinders University · AUSouth Australian Health and Medical Research Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cellular defense mechanisms against cumulative endo-lysosomal stress remain incompletely understood. Here, we identify Ubr1 as a protein quality control (QC) E3 ubiquitin-ligase that counteracts proteostasis stresses by facilitating endosomal cargo-selective autophagy for lysosomal degradation. Astrocyte regulatory cluster membrane protein MLC1 mutations cause endosomal compartment stress by fusion and enlargement. Partial lysosomal clearance of mutant endosomal MLC1 is accomplished by the endosomal QC ubiquitin ligases, CHIP and Ubr1 via ESCRT-dependent route. As a consequence of the endosomal stress, a supportive QC mechanism, dependent on both Ubr1 and SQSTM1/p62 activities, targets ubiquitinated and arginylated MLC1 mutants for selective endosomal autophagy (endophagy). This QC pathway is also activated for arginylated Ubr1-SQSTM1/p62 autophagy cargoes during cytosolic Ca

Indexed as

AnimalsArginineAutophagyCalciumCell Line, TumorCHO CellsCricetulusEndosomesHeLa CellsHumansLysosomesProteolysisProteostasisSignal TransductionUbiquitinUbiquitin-Protein LigasesArginineCalciumUbiquitinUbiquitin-Protein LigasesUBR1 protein, humanLysosomeProtein homeostasis networkProtein stabilityRegenerationReprogrammingStress response

Identifiers

PMID35233680
PMCPMC8888484
OpenAlexW4220788803

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.